Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
74
UBSI Quote, Financials, Valuation and Earnings
Last price:
$45.06
Seasonality move
:
1%
Day range:
$44.85 - $45.63
52-week range:
$30.51 - $45.93
Dividend yield:
3.31%
P/E ratio:
13.80x
P/S ratio:
3.51x
P/B ratio:
1.14x
Volume:
570.1K
Avg. volume:
932.5K
1-year change:
16.74%
Market cap:
$6.3B
Revenue:
$1.8B
EPS (TTM):
$3.26
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $867.5M | $1.1B | $1.5B | $1.6B | $1.8B | |
| Revenue Growth (YoY) | 0.06% | 27.39% | 36.04% | 7.92% | 12.25% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $2.7M | $776K | -$7.6M | -$7.7M | -- | |
| Operating Expenses | -$251.9M | -$424.8M | -$436.2M | -$464.6M | -$583.4M | |
| Operating Income | $251.9M | $424.8M | $436.2M | $464.6M | $583.4M | |
| Net Interest Expenses | $10.8M | $25.3M | $90.3M | $51.2M | $29.2M | |
| EBT. Incl. Unusual Items | $462.9M | $475.8M | $463.8M | $464.6M | $583.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $95.1M | $96.2M | $97.5M | $91.6M | $118.8M | |
| Net Income to Company | $367.7M | $379.6M | $366.3M | $373M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $366.7M | $378.6M | $365.4M | $372.2M | $464.6M | |
| Basic EPS (Cont. Ops) | $2.84 | $2.81 | $2.72 | $2.76 | $3.28 | |
| Diluted EPS (Cont. Ops) | $2.83 | $2.80 | $2.71 | $2.75 | $3.27 | |
| Weighted Average Basic Share | $129.3M | $134.8M | $134.5M | $134.9M | $141.5M | |
| Weighted Average Diluted Share | $129.5M | $135.1M | $134.8M | $135.2M | $141.8M | |
| EBITDA | -- | $605M | $968.3M | $1.1B | -- | |
| EBIT | $515.2M | $581.3M | $945.2M | $1.1B | $1.2B | |
| Revenue (Reported) | $867.5M | $1.1B | $1.5B | $1.6B | $1.8B | |
| Operating Income (Reported) | $251.9M | $424.8M | $436.2M | $464.6M | $583.4M | |
| Operating Income (Adjusted) | $515.2M | $581.3M | $945.2M | $1.1B | $1.2B | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $221.9M | $331.2M | $397.1M | $405.1M | $461.1M | |
| Revenue Growth (YoY) | -1.72% | 49.24% | 19.92% | 2% | 13.84% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -$39K | $51K | $276K | -$688K | -- | |
| Operating Expenses | -$69.1M | -$117M | -$96.8M | -$121.1M | -$159.9M | |
| Operating Income | $69.1M | $117M | $96.8M | $121.1M | $159.9M | |
| Net Interest Expenses | $2.7M | $14.1M | $17.4M | $7.7M | $7M | |
| EBT. Incl. Unusual Items | $93.3M | $126.4M | $104.2M | $121.1M | $159.9M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $19.5M | $26.6M | $24.8M | $26.7M | $31.1M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $73.6M | $99.5M | $79.2M | $94.2M | $128.8M | |
| Basic EPS (Cont. Ops) | $0.56 | $0.74 | $0.59 | $0.70 | $0.92 | |
| Diluted EPS (Cont. Ops) | $0.56 | $0.74 | $0.59 | $0.69 | $0.91 | |
| Weighted Average Basic Share | $130.9M | $134.3M | $134.7M | $135.2M | $140.5M | |
| Weighted Average Diluted Share | $131.3M | $134.8M | $135M | $135.7M | $141M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $104.9M | $184.7M | $243.7M | $264.5M | $302.5M | |
| Revenue (Reported) | $221.9M | $331.2M | $397.1M | $405.1M | $461.1M | |
| Operating Income (Reported) | $69.1M | $117M | $96.8M | $121.1M | $159.9M | |
| Operating Income (Adjusted) | $104.9M | $184.7M | $243.7M | $264.5M | $302.5M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $895.5M | $1.1B | $1.5B | $1.6B | $1.8B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $2.7M | $776K | -$7.6M | -$7.7M | -- | |
| Operating Expenses | -$282.8M | -$424.4M | -$436.2M | -$451.7M | -$583.4M | |
| Operating Income | $282.8M | $424.4M | $436.2M | $451.7M | $583.4M | |
| Net Interest Expenses | $10.8M | $25.3M | $90.3M | $51.2M | $29.2M | |
| EBT. Incl. Unusual Items | $462.9M | $475.8M | $463.8M | $464.6M | $583.4M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $95.1M | $96.2M | $97.5M | $91.6M | $118.8M | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $366.7M | $378.6M | $365.4M | $372.2M | $463.9M | |
| Basic EPS (Cont. Ops) | $2.84 | $2.81 | $2.71 | $2.75 | $3.28 | |
| Diluted EPS (Cont. Ops) | $2.83 | $2.80 | $2.71 | $2.75 | $3.26 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $515.2M | $581.3M | $945.2M | $1.1B | $1.2B | |
| Revenue (Reported) | $895.5M | $1.1B | $1.5B | $1.6B | $1.8B | |
| Operating Income (Reported) | $282.8M | $424.4M | $436.2M | $451.7M | $583.4M | |
| Operating Income (Adjusted) | $515.2M | $581.3M | $945.2M | $1.1B | $1.2B | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.1B | $1.5B | $1.6B | $1.8B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | $776K | -$7.6M | -$7.7M | $946K | -- | |
| Operating Expenses | -$424.4M | -$436.2M | -$451.7M | -$583.4M | -- | |
| Operating Income | $424.4M | $436.2M | $451.7M | $583.4M | -- | |
| Net Interest Expenses | $25.3M | $90.3M | $51.2M | $29.2M | -- | |
| EBT. Incl. Unusual Items | $475.8M | $463.8M | $464.6M | $583.4M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $96.2M | $97.5M | $91.6M | $118.8M | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $378.6M | $365.4M | $372.2M | $463.9M | -- | |
| Basic EPS (Cont. Ops) | $2.81 | $2.71 | $2.75 | $3.28 | -- | |
| Diluted EPS (Cont. Ops) | $2.80 | $2.71 | $2.75 | $3.26 | -- | |
| Weighted Average Basic Share | $539.1M | $538.5M | $540.3M | $566.6M | -- | |
| Weighted Average Diluted Share | $540.7M | $539.6M | $541.7M | $568.1M | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $581.3M | $945.2M | $1.1B | $1.2B | -- | |
| Revenue (Reported) | $1.1B | $1.5B | $1.6B | $1.8B | -- | |
| Operating Income (Reported) | $424.4M | $436.2M | $451.7M | $583.4M | -- | |
| Operating Income (Adjusted) | $581.3M | $945.2M | $1.1B | $1.2B | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $282.9M | $294.2M | $257.2M | $240.7M | $2.5B | |
| Short Term Investments | $4B | $4.5B | $3.8B | $261.5M | -- | |
| Accounts Receivable, Net | $64.5M | $94.9M | $111.4M | $102.4M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.8B | $1.3B | $1.7B | $2.4B | $2.6B | |
| Property Plant And Equipment | $279.2M | $270.3M | $277.5M | $267.9M | $89.3M | |
| Long-Term Investments | $4B | $1.3B | $1.7B | $2.4B | $336.5M | |
| Goodwill | $1.9B | $1.9B | $1.9B | $1.9B | -- | |
| Other Intangibles | $23.1M | $21M | $4.6M | $8.9M | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $29.4B | $29.5B | $30B | $30.1B | $33.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $176.1M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $19.7B | $20.7B | $22.8B | $22.9B | $6.8B | |
| Long-Term Debt | $365.1M | $355.9M | $365.7M | $349.9M | $627.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.7B | $25B | $25.2B | $25.1B | $28.2B | |
| Common Stock | $353.4M | $355M | $355.6M | $356.7M | -- | |
| Other Common Equity Adj | -$4.9M | -$332.7M | -$259.7M | -$223.9M | -- | |
| Common Equity | $4.7B | $4.5B | $4.8B | $5B | $5.5B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.7B | $4.5B | $4.8B | $5B | $5.5B | |
| Total Liabilities and Equity | $29.4B | $29.5B | $30B | $30.1B | $33.7B | |
| Cash and Short Terms | $7.8B | $5.7B | $5.4B | $2.6B | -- | |
| Total Debt | $884.6M | $2.3B | $1.9B | $610.1M | $627.2M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $282.9M | $294.2M | $257.2M | $240.7M | $2.5B | |
| Short Term Investments | $4B | $4.5B | $3.8B | $261.5M | -- | |
| Accounts Receivable, Net | $64.5M | $94.9M | $111.4M | $102.4M | -- | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $3.8B | $1.3B | $1.7B | $2.4B | $2.6B | |
| Property Plant And Equipment | $279.2M | $270.3M | $277.5M | $267.9M | $89.3M | |
| Long-Term Investments | $4B | $1.3B | $1.7B | $2.4B | $336.5M | |
| Goodwill | $1.9B | $1.9B | $1.9B | $1.9B | -- | |
| Other Intangibles | $23.1M | $21M | $4.6M | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $29.4B | $29.5B | $30B | $30.1B | $33.7B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | $176.1M | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $18.1B | $20.7B | $22.8B | $22.9B | $6.8B | |
| Long-Term Debt | $365.1M | $355.9M | $365.7M | $349.9M | $627.2M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $24.7B | $25B | $25.2B | $25.1B | $28.2B | |
| Common Stock | $353.4M | $355M | $355.6M | $356.7M | -- | |
| Other Common Equity Adj | -$4.9M | -$332.7M | -$259.7M | -$223.9M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $4.7B | $4.5B | $4.8B | $5B | $5.5B | |
| Total Liabilities and Equity | $29.4B | $29.5B | $30B | $30.1B | $33.7B | |
| Cash and Short Terms | $7.8B | $5.7B | $5.4B | $2.6B | -- | |
| Total Debt | $884.6M | $2.3B | $1.9B | $610.1M | $627.2M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $289M | $367.7M | $379.6M | $366.3M | $373M | |
| Depreciation & Amoritzation | -$16.4M | $7.9M | $23.7M | $23.1M | $10.4M | |
| Stock-Based Compensation | $6M | $8M | $9.9M | $12.5M | $12.1M | |
| Change in Accounts Receivable | $1.1M | $2.6M | -$30.4M | -$16.5M | $9M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $140M | $233.9M | $426.7M | $408.7M | $445.5M | |
| Capital Expenditures | $19M | $100.4M | $16.9M | $11.7M | $12.1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $138M | $391.3M | -$3.1B | $65.5M | $571.5M | |
| Dividends Paid (Ex Special Dividend) | $162.7M | $181.3M | $193M | $194.7M | $200.7M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $500M | $500M | $1.9B | $1.5B | $250M | |
| Long-Term Debt Repaid | -$1.8B | -$597.8M | -$520M | -$1.9B | -$1.5B | |
| Repurchase of Common Stock | $21.3M | $11.2M | $79.5M | $1.4M | $1M | |
| Other Financing Activities | $1K | -- | -- | -- | -- | |
| Cash From Financing | $1.1B | $923.9M | $105.3M | -$51.9M | -$323.6M | |
| Beginning Cash (CF) | $837.5M | $2.2B | $3.8B | $1.2B | $1.6B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.4B | $1.5B | -$2.6B | $422.3M | $693.3M | |
| Ending Cash (CF) | $2.2B | $3.8B | $1.2B | $1.6B | $2.3B | |
| Levered Free Cash Flow | $121M | $133.5M | $409.8M | $397.1M | $433.3M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$319.3M | -$197.1M | $136.1M | $136.3M | -- | |
| Capital Expenditures | $4M | $5M | $3.2M | $2.8M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $141.9M | -$294.9M | -$223.1M | $165.9M | -- | |
| Dividends Paid (Ex Special Dividend) | $45.3M | $48.6M | $48.7M | $50.2M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.4B | $400M | -- | -- | |
| Long-Term Debt Repaid | -$47.8M | -$500M | -- | -- | -- | |
| Repurchase of Common Stock | $1K | $1K | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$98M | $312.3M | $501.9M | $81.2M | -- | |
| Beginning Cash (CF) | $4B | $1.4B | $1.2B | $1.9B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$275.4M | -$179.7M | $414.9M | $383.4M | -- | |
| Ending Cash (CF) | $3.8B | $1.2B | $1.6B | $2.3B | -- | |
| Levered Free Cash Flow | -$323.3M | -$202.1M | $132.9M | $133.5M | -- | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $233.9M | $426.7M | $408.7M | $445.5M | -- | |
| Capital Expenditures | $100.4M | $16.9M | $11.7M | $12.1M | $12.3M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $391.3M | -$3.1B | $65.5M | $571.5M | -- | |
| Dividends Paid (Ex Special Dividend) | $181.3M | $193M | $194.7M | $200.7M | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $500M | $1.9B | $1.5B | $250M | -- | |
| Long-Term Debt Repaid | -$597.8M | -$520M | -$1.9B | -$1.5B | -- | |
| Repurchase of Common Stock | $11.2M | $79.5M | $1.4M | $1M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $923.9M | $105.3M | -$51.9M | -$323.6M | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $1.5B | -$2.6B | $422.3M | $693.3M | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $133.5M | $409.8M | $397.1M | $433.3M | -- | |
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $426.7M | $408.7M | $445.5M | $360M | -- | |
| Capital Expenditures | $16.9M | $11.7M | $12.1M | $12.3M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.1B | $65.5M | $571.5M | -$676.6M | -- | |
| Dividends Paid (Ex Special Dividend) | $193M | $194.7M | $200.7M | $156.5M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $1.9B | $1.5B | $250M | -- | -- | |
| Long-Term Debt Repaid | -$520M | -$1.9B | -$1.5B | -$10M | -- | |
| Repurchase of Common Stock | $79.5M | $1.4M | $1M | $79.4M | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $105.3M | -$51.9M | -$323.6M | $543.1M | -- | |
| Beginning Cash (CF) | $9.6B | $6B | $7.1B | $2.3B | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.6B | $422.3M | $693.3M | $226.5M | -- | |
| Ending Cash (CF) | $7B | $6.4B | $7.8B | $2.6B | -- | |
| Levered Free Cash Flow | $409.8M | $397.1M | $433.3M | $347.7M | -- | |
Get UBSI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
UBSI
Sector
P/E ratio
13.80x
12.54x
PEG ratio
0.74x
0.32x
P/B ratio
1.14x
1.15x
Price / LTM sales
3.51x
1.86x
Growth Metrics
UBSI
Sector
Revenue growth
13.84%
5.54%
Earnings growth
31.12%
11.36%
Revenue (5-year growth)
16%
8.68%
Earnings forecast
$0.86
$0.64
Profitability
UBSI
Sector
Profitability FY 2025
--
--
Return on invested capital
7.56%
5.2%
Return on assets
1.43%
1.03%
Return on equity
8.72%
9.91%
Earnings Date
Last Earnings Date
Jan
22
Next Earnings Date
Apr
23
Estimated Next Earnings Date
Apr
23
Balance Sheet
UBSI
Sector
Total cash
$5.4B
$407.2M
Short term investments
$261.5M
$192.4M
Total assets
$33.7B
$3.1B
Long term debt
$627.2M
$59.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
53
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 30x
Alerts
Buy
67
PRLB alert for Feb 10
Proto Labs, Inc. [PRLB] is down 2.16% over the past day.
Sell
33
MSTR alert for Feb 10
Strategy, Inc. [MSTR] is up 2.59% over the past day.
Sell
10
MOH alert for Feb 10
Molina Healthcare, Inc. [MOH] is down 3% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
